After the original discovery that MALAT1 is overexpressed in NSCLC, several other studies have been published showing the overexpression of MALAT1 in a multitude of cancer types such as colorectal, breast, pancreas, bladder, and prostate cancers (Lin et al., 2007; Han et al., 2013). This evidence concerns the gene MALAT1 and Familial prostate cancer.